Brasília – A new nationwide survey has mapped the distribution of clinical research activity in Brazil, revealing significant regional disparities and concentration of studies in a limited number of states. Conducted by the Brazilian Clinical Research Alliance (Abracro) in partnership with CT•VI Research, the study shows that São Paulo, Rio de Janeiro, Minas Gerais and Rio Grande do Sul account for the majority of clinical trials, while vast regions of the country remain underrepresented. The findings underscore structural challenges such as uneven research infrastructure, shortage of qualified personnel and limited institutional support outside major urban centers.

The report emphasizes the potential economic and scientific gains of expanding clinical research capacity nationwide, including improved patient access to innovative therapies and strengthened collaboration with global sponsors. Industry representatives argue that regulatory modernization, investment in research networks and incentives for institutional development are essential to reduce inequities and position Brazil as a more competitive hub for clinical trials.

Source: Futuro da Saúde